These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27322314)

  • 1. Age and Alzheimer's Disease.
    Meunier B
    Nutrients; 2016 Jun; 8(6):. PubMed ID: 27322314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies.
    Ventriglia M; Bucossi S; Panetta V; Squitti R
    J Alzheimers Dis; 2012; 30(4):981-4. PubMed ID: 22475798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
    Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
    J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How reliable and robust are current biomarkers for copper status?--comments by Brewer and Althaus.
    Brewer GJ; Althaus J
    Br J Nutr; 2008 Dec; 100(6):1341-2; discussion 1343-4. PubMed ID: 18341759
    [No Abstract]   [Full Text] [Related]  

  • 5. The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease.
    Brewer GJ
    J Am Coll Nutr; 2009 Jun; 28(3):238-42. PubMed ID: 20150596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of various mammalian models to study chronic copper intoxication associated Alzheimer's disease like pathology.
    Pal A; Prasad R
    Biometals; 2015 Feb; 28(1):1-9. PubMed ID: 25307560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease.
    Brewer GJ
    Exp Biol Med (Maywood); 2007 Feb; 232(2):323-35. PubMed ID: 17259340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease linked to brain copper buildup.
    Rosania K
    Lab Anim (NY); 2013 Oct; 42(10):346. PubMed ID: 24051629
    [No Abstract]   [Full Text] [Related]  

  • 9. Famous forgetters: notable people and Alzheimer's disease.
    Jones JM; Jones JL
    Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):116-8. PubMed ID: 19949162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild alzheimer's disease.
    Morris JC
    J Clin Invest; 1999 Nov; 104(9):1171-3. PubMed ID: 10545515
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevation of serum copper levels in Alzheimer's disease.
    Brenner S
    Neurology; 2003 May; 60(9):1559; author 1559. PubMed ID: 12743263
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease.
    Squitti R; Simonelli I; Ventriglia M; Siotto M; Pasqualetti P; Rembach A; Doecke J; Bush AI
    J Alzheimers Dis; 2014; 38(4):809-22. PubMed ID: 24072069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    Siotto M; Simonelli I; Pasqualetti P; Mariani S; Caprara D; Bucossi S; Ventriglia M; Molinario R; Antenucci M; Rongioletti M; Rossini PM; Squitti R
    J Alzheimers Dis; 2016; 50(4):1181-9. PubMed ID: 26836154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.
    Wang ZX; Tan L; Wang HF; Ma J; Liu J; Tan MS; Sun JH; Zhu XC; Jiang T; Yu JT
    J Alzheimers Dis; 2015; 47(3):565-81. PubMed ID: 26401693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies.
    Bucossi S; Ventriglia M; Panetta V; Salustri C; Pasqualetti P; Mariani S; Siotto M; Rossini PM; Squitti R
    J Alzheimers Dis; 2011; 24(1):175-85. PubMed ID: 21187586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
    Rembach A; Doecke JD; Roberts BR; Watt AD; Faux NG; Volitakis I; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Wilson W; Ellis KA; Martins RN; Rowe CC; Villemagne VL; Ames D; Masters CL; AIBL research group ; Bush AI
    J Alzheimers Dis; 2013; 34(1):171-82. PubMed ID: 23168449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeostasis of metals in the progression of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Biometals; 2014 Jun; 27(3):539-49. PubMed ID: 24668390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risks of free copper in the body and the development of useful anticopper drugs.
    Brewer GJ
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):727-32. PubMed ID: 18827576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum nerve growth factor concentration and its role in the preclinical stage of dementia.
    Schaub RT; Anders D; Golz G; Göhringer K; Hellweg R
    Am J Psychiatry; 2002 Jul; 159(7):1227-9. PubMed ID: 12091204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
    Squitti R; Pasqualetti P; Dal Forno G; Moffa F; Cassetta E; Lupoi D; Vernieri F; Rossi L; Baldassini M; Rossini PM
    Neurology; 2005 Mar; 64(6):1040-6. PubMed ID: 15781823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.